PROVIGIL is the first non-amphetamine drug in 40 years to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy. PROVIGIL is a new molecular entity that is chemically unrelated to CNS stimulants (e.g., amphetamine and methylphenidate).